中西医结合治疗脾胃湿热型幽门螺杆菌相关性慢性胃炎的临床观察

发布时间：2018-06-24 11:26

本文选题：西医治疗 + 脾胃湿热型　；参考：《中外医学研究》2017年35期

【摘要】：目的:分析脾胃湿热型幽门螺杆菌相关性慢性胃炎治疗中实施中西医结合治疗方案的效果。方法:选取2016年2月-2017年2月进入笔者所在医院治疗的脾胃湿热型幽门螺杆菌相关性慢性胃炎患者83例进行分析,随机分为两组,常规组41例选择西医治疗,治疗组42例选择中西医结合治疗方案,分析两组疗效以及Hp清除情况。结果:两组脾胃湿热型幽门螺杆菌相关性慢性胃炎患者实施不同治疗方案后,常规组总有效率为73.17%,明显低于治疗组的95.24%(P0.05);常规组Hp清除率为68.29%,明显低于治疗组的90.47%(P0.05);治疗组中医症候积分为(3.10±0.20)分,明显低于常规组的(6.20±1.22)分(P0.05)。结论:对于脾胃湿热型幽门螺杆菌相关性慢性胃炎症状的患者,选择中西医结合治疗方案疗效优越,值得应用。
[Abstract]:Objective: to analyze the effect of integrated Chinese and western medicine in the treatment of Helicobacter pylori associated chronic gastritis of damp-heat type of spleen and stomach. Methods: from February 2016 to February 2017, 83 patients with Helicobacter pylori associated chronic gastritis were selected and randomly divided into two groups. 41 patients in the routine group were treated with western medicine. 42 patients in the treatment group were treated with the combination of traditional Chinese and western medicine, and the curative effect and HP clearance were analyzed. Results: two groups of patients with Helicobacter pylori associated chronic gastritis were treated with different treatments. The total effective rate of the routine group was 73.17, significantly lower than that of the treatment group (95.24%, P0.05); the HP clearance rate of the routine group was 68.29, significantly lower than that of the treatment group (90.47%) (P0.05); the TCM symptom score of the treatment group was (3.10 卤0.20), significantly lower than that of the conventional group (6.20 卤1.22) (P0.05). Conclusion: for the patients with chronic gastritis associated with Helicobacter pylori, the combination of traditional Chinese and Western medicine is effective and worthy of application.
【作者单位】：南京市高淳人民医院;
【分类号】：R573.3

【相似文献】